ATE188378T1 - Liposompräparat enthaltend eine tricyclische verbindung - Google Patents

Liposompräparat enthaltend eine tricyclische verbindung

Info

Publication number: ATE188378T1
Authority: AT; Austria
Prior art keywords: tricyclic compound; preparation containing; liposome; liposome preparation; incorporated
Prior art date: 1991-10-31

Application number

AT92921787T

Other languages

English (en)

Inventor

Akira Kagayama

Yuji Tokunaga

Atsunori Kaibara

Sachiyo Tanimoto

Takehisa Hata

Original Assignee

Fujisawa Pharmaceutical Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1991-10-31

Filing date

1992-10-26

Publication date

2000-01-15

1992-10-26 Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co

2000-01-15 Application granted granted Critical

2000-01-15 Publication of ATE188378T1 publication Critical patent/ATE188378T1/de

Links

239000002502 liposome Substances 0.000 title abstract 4
150000001875 compounds Chemical class 0.000 title abstract 3
239000003814 drug Substances 0.000 abstract 1
229940079593 drug Drugs 0.000 abstract 1
230000001506 immunosuppresive effect Effects 0.000 abstract 1
230000002688 persistence Effects 0.000 abstract 1
239000000825 pharmaceutical preparation Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Dispersion Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

AT92921787T 1991-10-31 1992-10-26 Liposompräparat enthaltend eine tricyclische verbindung ATE188378T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP31342291		1991-10-31
PCT/JP1992/001388 WO1993008802A1 (fr)	1991-10-31	1992-10-26	Preparation de liposome contenant un compose tricyclique

Publications (1)

Publication Number	Publication Date
ATE188378T1 true ATE188378T1 (de)	2000-01-15

Family

ID=18041109

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT92921787T ATE188378T1 (de)	1991-10-31	1992-10-26	Liposompräparat enthaltend eine tricyclische verbindung

Country Status (9)

Country	Link
EP (1)	EP0658344B1 (de)
KR (1)	KR100253492B1 (de)
AT (1)	ATE188378T1 (de)
CA (1)	CA2122344C (de)
DE (1)	DE69230541T2 (de)
DK (1)	DK0658344T3 (de)
ES (1)	ES2140419T3 (de)
GR (1)	GR3032319T3 (de)
WO (1)	WO1993008802A1 (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB9601120D0 (en)	1996-01-19	1996-03-20	Sandoz Ltd	Organic compounds
BR0010459A (pt) *	1999-03-11	2002-02-05	Fujisawa Pharmaceutical Co	Preparação de lipossoma contendo derivado de ácido pipecólico e preparação sólida
KR20020063873A (ko)	1999-10-18	2002-08-05	후지사와 야꾸힝 고교 가부시키가이샤	리포좀 제제의 제조방법
US20040018228A1 (en) *	2000-11-06	2004-01-29	Afmedica, Inc.	Compositions and methods for reducing scar tissue formation
WO2006115509A2 (en)	2004-06-24	2006-11-02	Novartis Vaccines And Diagnostics Inc.	Small molecule immunopotentiators and assays for their detection
US20150157610A1 (en) *	2012-05-23	2015-06-11	Osaka University	Pharmaceutical composition for treating inflammatory disease
CN115786419A (zh) *	2022-12-12	2023-03-14	无锡福祈制药有限公司	一种制备他克莫司脂质体的方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8430455D0 (en) *	1984-12-03	1985-01-09	Fujisawa Pharmaceutical Co	Fr-900506 substance
JPH0655676B2 (ja) *	1984-07-26	1994-07-27	ザリポソ−ムカンパニ−、インコ−ポレ−テツド	脂質小胞体中に含有された抗菌物質の混合物による抗菌活性の増高
JP2838164B2 (ja) *	1988-09-29	1998-12-16	株式会社資生堂	乳化組成物
DK0406791T3 (da) *	1989-07-05	1995-03-27	Fujisawa Pharmaceutical Co	Vandigt flydende præparat til ekstern anvendelse
AU8007791A (en) *	1990-06-15	1992-01-07	Cytel Corporation	Intercellular adhesion mediators

1992
- 1992-10-26 EP EP92921787A patent/EP0658344B1/de not_active Expired - Lifetime
- 1992-10-26 DK DK92921787T patent/DK0658344T3/da active
- 1992-10-26 AT AT92921787T patent/ATE188378T1/de active
- 1992-10-26 WO PCT/JP1992/001388 patent/WO1993008802A1/ja not_active Ceased
- 1992-10-26 DE DE69230541T patent/DE69230541T2/de not_active Expired - Lifetime
- 1992-10-26 CA CA002122344A patent/CA2122344C/en not_active Expired - Lifetime
- 1992-10-26 ES ES92921787T patent/ES2140419T3/es not_active Expired - Lifetime
- 1992-10-26 KR KR1019940701328A patent/KR100253492B1/ko not_active Expired - Lifetime
2000
- 2000-01-07 GR GR990403375T patent/GR3032319T3/el unknown

Also Published As

Publication number	Publication date
CA2122344C (en)	2004-04-20
DE69230541T2 (de)	2000-08-24
CA2122344A1 (en)	1993-05-01
DK0658344T3 (da)	2000-04-17
DE69230541D1 (de)	2000-02-10
EP0658344B1 (de)	2000-01-05
ES2140419T3 (es)	2000-03-01
EP0658344A4 (de)	1995-03-02
KR100253492B1 (ko)	2000-05-01
GR3032319T3 (en)	2000-04-27
EP0658344A1 (de)	1995-06-21
WO1993008802A1 (fr)	1993-05-13

Similar Documents

Publication	Publication Date	Title
DE3650315D1 (de)	1995-06-08	Cyancrotonsäureamidverbindung als Arzneimittel mit immunmodulierenden Eigenschaften.
FI955091L (fi)	1995-12-14	Parannetut farmaseuttisesti hyväksyttävät seokset, jotka sisältävät alkoholia ja hydrofobista lääkettä
ATE112961T1 (de)	1994-11-15	Cimetidin enthaltende arzneimittel.
DE69813542D1 (de)	2003-05-22	Arzneizubereitung enthaltend eine trizyklische verbindung mit erhöter stabilität, absorbierbarkeit und niedriger reizungsneigung
DE69434479D1 (de)	2005-10-06	Tramadolhaltiges Arzneimittel mit gesteuerter Wirkstoffabgabe
ATE121089T1 (de)	1995-04-15	Optisch aktives 5h-pyrrolo(3,4-b>pyrazinderivat, seine herstellung und pharmazeutische zubereitungen die es enthalten.
FI951901L (fi)	1995-04-21	Stabiili pidennysti vapautuva, oraalisesti annosteltava koostumus
AU1225795A (en)	1995-05-04	Combinations of an organic nitrate and a salicylate
AU650484B2 (en)	1994-06-23	Isoxazole compound, pharmaceutically acceptable salt thereof, and medicinal use thereof
DE69228674D1 (de)	1999-04-22	Nichtsteroide-entzündungshemmende Arzneimittel und Decongestirum enthaltende Augenarzneimittelzusammensetzung
RU93058306A (ru)	1996-12-27	Моногидрат l-тартрата(-)-(s)-2,8-диметил-3-метилен-1-окса-8-азаспиро-(4,5)-декана
DE69006654D1 (de)	1994-03-24	Einen Zink-Komplex enthaltende Arzneimittel.
NO179586C (no)	1996-11-06	4,13-dioksabisyklo[8.2.1Åtridecenonderivater og legemidler inneholdene disse forbindelser
DE69230541D1 (de)	2000-02-10	Liposompräparat enthaltend eine tricyclische Verbindung
IL94806A0 (en)	1991-04-15	Pharmaceutical preparation containing thiol derivatives together with other active compounds
ATE128363T1 (de)	1995-10-15	Tablette mit verbesserter bioverfügbarkeit enthaltend dichlormethylendiphosphonsäure als wirkstoff.
HUT70955A (en)	1995-11-28	3,4-dihydro-1,1-dioxo-2h-1,2,4-benzothiadiazine-3-carboxylic acid derivatives, preparation thereof and drugs containing same
ATA124091A (de)	1996-08-15	Pharmazeutische präparation enthaltend eine thrombolytisch wirkende substanz
BR9106372A (pt)	1993-04-27	Derivados 1,5-benzotiazepinona,suas preparacoes e uso farmaceutico
CA2077762A1 (en)	1991-09-17	New use of bambuterol
KR910000645A (ko)	1991-01-29	개선된 경련치료제
NO923808D0 (no)	1992-09-30	Substituert sulfonamidderivat og farmasoeytisk formuleringinneholdende det samme
EP0676206A4 (de)	1995-10-25
ITMI911344A1 (it)	1992-11-16	Associazione farmaceutica ad attivita' antineoplastica
AP9200405A0 (en)	1994-01-13	Pharmaceutical formulations comprised of micronised halofantrine.

Legal Events

Date	Code	Title	Description
2000-05-15	UEP	Publication of translation of european patent specification